KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentBeginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Change in Receivables (2017 - 2026)

Amneal Pharmaceuticals has reported Change in Receivables over the past 9 years, most recently at $10.3 million for Q4 2025.

  • For Q4 2025, Change in Receivables fell 63.86% year-over-year to $10.3 million; the TTM value through Dec 2025 reached $120.6 million, down 25.87%, while the annual FY2025 figure was $120.6 million, 25.87% down from the prior year.
  • Change in Receivables for Q4 2025 was $10.3 million at Amneal Pharmaceuticals, down from $77.6 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $150.8 million in Q2 2022 and troughed at -$196.0 million in Q1 2023.
  • A 5-year average of $12.1 million and a median of $14.1 million in 2023 define the central range for Change in Receivables.
  • Biggest five-year swings in Change in Receivables: crashed 277.99% in 2021 and later surged 1474.34% in 2022.
  • Year by year, Change in Receivables stood at $5.0 million in 2021, then surged by 1474.34% to $78.7 million in 2022, then plummeted by 198.12% to -$77.2 million in 2023, then skyrocketed by 137.04% to $28.6 million in 2024, then crashed by 63.86% to $10.3 million in 2025.
  • Business Quant data shows Change in Receivables for AMRX at $10.3 million in Q4 2025, $77.6 million in Q3 2025, and $53.8 million in Q2 2025.